Massachusetts Institute of Technology Buys MongoDB Inc, LexinFintech Holdings, PPDAI Group Inc, Sells Audentes Therapeutics Inc

Aug 09, 2019

Investment company Massachusetts Institute of Technology (Current Portfolio) buys MongoDB Inc, LexinFintech Holdings, PPDAI Group Inc, sells Audentes Therapeutics Inc during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Massachusetts Institute of Technology. As of 2019Q2, Massachusetts Institute of Technology owns 6 stocks with a total value of $104 million. These are the details of the buys and sells.

New Purchases: MDB, LX, PPDF,
Reduced Positions: JBGS,
Sold Out: BOLD,

For the details of Massachusetts Institute of Technology's stock buys and sells, go to https://www.gurufocus.com/guru/massachusetts+institute+of+technology/current-portfolio/portfolioportfolio

These are the top 5 holdings of Massachusetts Institute of Technology

JBG SMITH Properties (JBGS) - 1,290,243 shares, 48.61% of the total portfolio. Shares reduced by 16.67%
Boston Omaha Corp (BOMN) - 2,070,328 shares, 45.90% of the total portfolio.
MongoDB Inc (MDB) - 14,557 shares, 2.12% of the total portfolio. New Position
LexinFintech Holdings Ltd (LX) - 163,600 shares, 1.75% of the total portfolio. New Position
Textron Inc (TXT) - 16,000 shares, 0.81% of the total portfolio.

New Purchase: MongoDB Inc (MDB)

Massachusetts Institute of Technology initiated holding in MongoDB Inc. The purchase prices were between $125.38 and $174.01, with an estimated average price of $144.78. The stock is now traded at around $148.90. The impact to a portfolio due to this purchase was 2.12%. The holding were 14,557 shares as of .

New Purchase: LexinFintech Holdings Ltd (LX)

Massachusetts Institute of Technology initiated holding in LexinFintech Holdings Ltd. The purchase prices were between $10.66 and $14.5, with an estimated average price of $12.49. The stock is now traded at around $10.26. The impact to a portfolio due to this purchase was 1.75%. The holding were 163,600 shares as of .

New Purchase: PPDAI Group Inc (PPDF)

Massachusetts Institute of Technology initiated holding in PPDAI Group Inc. The purchase prices were between $3.81 and $6.02, with an estimated average price of $4.93. The stock is now traded at around $3.45. The impact to a portfolio due to this purchase was 0.81%. The holding were 193,615 shares as of .

Sold Out: Audentes Therapeutics Inc (BOLD)

Massachusetts Institute of Technology sold out a holding in Audentes Therapeutics Inc. The sale prices were between $35.12 and $41, with an estimated average price of $38.42.

Here is the complete portfolio of Massachusetts Institute of Technology. Also check out:

1. Massachusetts Institute of Technology's Undervalued Stocks
2. Massachusetts Institute of Technology's Top Growth Companies, and
3. Massachusetts Institute of Technology's High Yield stocks
4. Stocks that Massachusetts Institute of Technology keeps buying

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Data is updated daily.